Article Text

Download PDFPDF

Response to: ‘Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic’ by Lecler et al
  1. Sara Monti1,2,
  2. Carlomaurizio Montecucco1
  1. 1Department of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
  2. 2Experimental Medicine, University of Pavia, Pavia, Italy
  1. Correspondence to Dr Sara Monti, Rheumatology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; sara.saramonti{at}

Statistics from

We appreciate the correspondence from Lecler et al1 in response to our paper highlighting the impact of the COVID-19 epidemic on the delayed diagnosis of giant cell arteritis (GCA) leading to an increased rate of bilateral blindness.2

The colleagues described their experience with a similar fast-track clinic for the early diagnosis of GCA, reporting an increased incidence of GCA during the lockdown period without an increase in the severity or complications of the disease, nor an increase in referral delay. Interestingly, Lecler et al specified that their centre was not a referral centre for COVID-19 and that …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles